The Serbian Commission for Protection of Competition (CPC) has denied Roche and ADOC's request to extend their exclusive distribution agreement exemption, marking a significant shift in regulatory oversight. This July 2024 decision affects the distribution of three crucial pharmaceuticals: Kadcyla, Perjeta, and Tecentriq.
Radovanović Stojanović & Partners advised British American Tobacco on a sidestream merger of its Serbian subsidiaries British American Tobacco South-East Europe doo Beograd (as the transferring entity) and British American Tobacco Vranje ad (as the surviving entity).
On 4 July 2024 the Serbian competition regulator – the Commission for Protection of Competition (“CPC”) published its draft proposals of four new regulations on exemption of certain categories of agreements from the prohibition of restrictive agreements (block exemption regulations, “BERs”).
On 29 February 2024, the Serbian Commission for Protection of Competition ("CPC") published its infringement decision against Atlantic Grupa d.d. and its Serbian subsidiaries, Atlantic Brands d.o.o. and Atlantic Grand d.o.o., ("Atlantic Group") and Strauss Adriatic d.o.o. ("Strauss") from 29 December 2023 ("Decision").
